August 3rd, 2004
Meanwhile, On The Front Lines...
The business world and private research community is forging ahead in the broad field of regenerative medicine, based both on stem cell research and other technologies. This press release and others like it show that at least some venture capital is flowing - the potential revenue that will result form from cures for diabetes, Parkinson's, Alzheimer's and other age-related conditions are too large to pass up, even in this currently hostile legislative environment. "It is very exciting to bring this work to a region that is already leading the way in regenerative medicine and tissue engineering. We want to build on Pittsburgh's reputation as a global leader in these areas, ultimately saving lives."